Gennex Lab.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE509C01026
NSEID:
BSEID: 531739
View on BSE

INR

10.27

-0.16 (-1.53%)

BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 3.12 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BDH Industries

Sanjiv.Parant.

Ambalal Sarabhai

Medico Remedies

Gennex Lab.

Lyka Labs

Zenotech Lab.

Kerala Ayurveda

Everest Organics

Accretion Pha.

Sat Kartar Life

Why is Gennex Laboratories Ltd ?

Flat results in Jun 26

PBDIT(Q) Lowest at Rs 4.38 cr.
PBT LESS OI(Q) Lowest at Rs 2.91 cr.
NON-OPERATING INCOME(Q) is 40.85 % of Profit Before Tax (PBT)

Underperformed the market in the last 1 year

Even though the market (BSE500) generated negative returns of -3.53% in the last 1 year, its fall in the stock was much higher with a return of -20.57%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Gennex Lab. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Gennex Lab.

-20.57%

-0.34

60.26%

Sensex

-10.5%

-0.78

13.50%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

26.14%

EBIT Growth (5y)

27.58%

EBIT to Interest (avg)

6.07

Debt to EBITDA (avg)

1.69

Net Debt to Equity (avg)

0.12

Sales to Capital Employed (avg)

0.80

Tax Ratio

7.45%

Dividend Payout Ratio

Pledged Shares

21.77%

Institutional Holding

0.00%

ROCE (avg)

12.32%

ROE (avg)

8.12%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.12

EV to EBIT

11.83

EV to EBITDA

10.47

EV to Capital Employed

1.11

EV to Sales

1.51

PEG Ratio

1.84

Dividend Yield

ROCE (Latest)

9.80%

ROE (Latest)

8.61%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET SALES(Latest six months)

At Rs 100.80 cr has Grown at 35.28%

-3What is not working for the Company

PBDIT(Q)

Lowest at Rs 4.38 cr.

PBT LESS OI(Q)

Lowest at Rs 2.91 cr.

NON-OPERATING INCOME(Q)

is 40.85 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Gennex Lab.

Net Sales - Latest six months

At Rs 100.80 cr has Grown at 35.28%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Gennex Lab.

Operating Profit (PBDIT) - Quarterly

Lowest at Rs 4.38 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at Rs 2.91 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly

is 40.85 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT